JPWO2006022430A1 - Fiber structure containing phospholipid - Google Patents

Fiber structure containing phospholipid Download PDF

Info

Publication number
JPWO2006022430A1
JPWO2006022430A1 JP2006532769A JP2006532769A JPWO2006022430A1 JP WO2006022430 A1 JPWO2006022430 A1 JP WO2006022430A1 JP 2006532769 A JP2006532769 A JP 2006532769A JP 2006532769 A JP2006532769 A JP 2006532769A JP WO2006022430 A1 JPWO2006022430 A1 JP WO2006022430A1
Authority
JP
Japan
Prior art keywords
weight
fiber structure
fiber
solution
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006532769A
Other languages
Japanese (ja)
Other versions
JP4354996B2 (en
Inventor
由佳子 福平
由佳子 福平
北薗 英一
英一 北薗
兼子 博章
博章 兼子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of JPWO2006022430A1 publication Critical patent/JPWO2006022430A1/en
Application granted granted Critical
Publication of JP4354996B2 publication Critical patent/JP4354996B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/88Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
    • D01F6/92Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of polyesters
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0015Electro-spinning characterised by the initial state of the material
    • D01D5/003Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning

Abstract

脂肪族ポリエステル100重量部に対して、リン脂質を0.01〜100重量部含有し、平均繊維径が0.05〜50μmであることを特徴とした繊維構造体。さらに好ましくは繊維表面に孔を有し、細胞培養に適した基材となる繊維構造体。A fiber structure containing 0.01 to 100 parts by weight of a phospholipid with respect to 100 parts by weight of an aliphatic polyester and having an average fiber diameter of 0.05 to 50 μm. More preferably, the fiber structure has pores on the fiber surface and serves as a base material suitable for cell culture.

Description

本発明はリン脂質を含有する繊維構造体に関する。さらに好ましくは繊維表面に孔を有し細胞培養に適した基材となる繊維構造体に関する。  The present invention relates to a fibrous structure containing a phospholipid. More preferably, the present invention relates to a fiber structure which has pores on the fiber surface and serves as a base material suitable for cell culture.

再生医療分野においては、細胞を培養する際に基材として多孔体が用いられることがある。多孔体としては凍結乾燥による発泡体や繊維構造体が知られている。これら多孔体は細胞との親和性や生体内分解性、安全性などが必要とされる。
ポリ乳酸は、これら生体内分解性や安全性が知られている材料の中でも比較的安価に入手可能である。特に、L−乳酸成分を主とするポリ乳酸は、最近大量に製造されている。
例えば、生体内分解性、安全性が知られているポリ乳酸の多孔体を細胞培養基材に用いることが検討されている(例えば大野典也、相澤益男監訳代表「再生医学」株式会社エヌ・ティー・エス、2002年1月31日、262頁参照。)。
しかしながら、これら方法は、細胞が接着できる面積は不十分であり、より表面積の大きい多孔体が望まれており、その一つとして繊維径の小さい繊維構造体が検討されてきた。
繊維径の小さい繊維構造体を製造する方法として、静電紡糸法が知られている(例えば、特開昭63−145465号公報および特開2002−249966号公報参照)。静電紡糸法は、液体、例えば繊維形成物質を含有する溶液等を電場内に導入し、これにより液体を電極に向かって曳かせ、繊維状物質を形成させる工程を包含する。普通、繊維形成物質は溶液から曳き出される間に硬化させる。硬化は、例えば冷却(例えば、紡糸液体が室温で固体である場合)、化学的硬化(例えば、硬化用蒸気による処理)、または溶媒の蒸発などにより行われる。また、得られる繊維状物質は、適宜に配置した受容体上に捕集され、必要ならばそこから剥離することも出来る。また、静電紡糸法は不織布状の繊維状物質を直接得ることが出来るため、一旦繊維を製糸した後、さらに繊維構造体を形成する必要がなく、操作が簡便である。
静電紡糸法によって得られる繊維構造体を、細胞を培養する基材に用いることも知られている。例えばポリ乳酸よりなる繊維構造体を静電紡糸法により形成し、この上で平滑筋細胞を培養することにより血管の再生が検討されている(例えばJoel D.Stitzel,Kristin J.Pawlowski,Gary E.Wnek,David G.Simpson,Gary L.Bowlin著、Journal of Biomaterials Applications 2001,16,22−33参照)。
しかしながら、これまでの報告ではまだ要求を満たすほどの細胞接着効果は得られていない。
In the field of regenerative medicine, a porous body may be used as a substrate when culturing cells. As a porous body, a foam or a fibrous structure obtained by freeze-drying is known. These porous materials are required to have affinity with cells, biodegradability and safety.
Polylactic acid is available at a relatively low cost among these materials known to be biodegradable and safe. In particular, polylactic acid, which is mainly composed of L-lactic acid component, has recently been produced in a large amount.
For example, the use of a porous body of polylactic acid, which is known to be biodegradable and safe, as a cell culture substrate has been studied (for example, "Regenerative Medicine" by Noriya Ohno and Masuo Aizawa. See TS, January 31, 2002, page 262.).
However, in these methods, the area to which cells can adhere is insufficient, and a porous body having a larger surface area is desired, and a fiber structure having a small fiber diameter has been studied as one of them.
An electrostatic spinning method is known as a method for producing a fiber structure having a small fiber diameter (see, for example, JP-A-63-145465 and JP-A-2002-249966). The electrospinning method includes a step of introducing a liquid, for example, a solution containing a fiber-forming substance, into an electric field, and thereby pulling the liquid toward an electrode to form a fibrous substance. Usually, the fiber-forming substance cures while being drawn from the solution. Curing is done, for example, by cooling (eg, when the spinning liquid is a solid at room temperature), chemical curing (eg, treatment with curing vapors), solvent evaporation, or the like. Further, the obtained fibrous substance is collected on an appropriately arranged receptor and, if necessary, can be peeled therefrom. Further, since the electrospinning method can directly obtain a non-woven fibrous substance, it is not necessary to form a fiber structure once the fibers are once spun, and the operation is simple.
It is also known to use the fiber structure obtained by the electrospinning method as a substrate for culturing cells. For example, regeneration of blood vessels has been studied by forming a fibrous structure made of polylactic acid by an electrostatic spinning method and culturing smooth muscle cells on the fibrous structure (for example, Joel D. Stitzel, Kristin J. Powlowski, Gary E. Wnek, David G. Simpson, Gary L. Bowlin, Journal of Biomaterials Applications 2001, 16, 22-33).
However, the reports so far have not yet obtained a cell adhesion effect sufficient to satisfy the demand.

本発明の課題は、再生医療分野において細胞培養に適した基材を提供することにある。
すなわち、本発明は、脂肪族ポリエステル100重量部に対して、リン脂質を0.01〜100重量部含有し、平均繊維径が0.05〜50μmであることを特徴とした繊維構造体に関するものである。本発明はさらに好ましくは繊維構造体の繊維表面の平均多孔化率が3%〜90%である繊維構造体に関するものである。
発明の効果
本発明のリン脂質を含有する繊維構造体により、細胞接着性が向上した繊維構造体を提供することができ、再生医療分野においてとくに有効である。
An object of the present invention is to provide a substrate suitable for cell culture in the field of regenerative medicine.
That is, the present invention relates to a fiber structure characterized by containing 0.01 to 100 parts by weight of phospholipid with respect to 100 parts by weight of aliphatic polyester and having an average fiber diameter of 0.05 to 50 μm. Is. The present invention more preferably relates to a fiber structure having an average porosity of 3% to 90% on the fiber surface of the fiber structure.
EFFECTS OF THE INVENTION The fiber structure containing the phospholipid of the present invention can provide a fiber structure with improved cell adhesion, and is particularly effective in the field of regenerative medicine.

本発明の製造方法のなかで、紡糸液を静電場中に吐出する静電紡糸法で用いる装置の一例である。It is an example of an apparatus used in the electrospinning method of discharging a spinning solution into an electrostatic field in the production method of the present invention. 本発明の製造方法のなかで、紡糸液の微細滴を静電場中に導入する静電紡糸法で用いる装置の一例である。It is an example of an apparatus used in the electrospinning method of introducing fine droplets of a spinning solution into an electrostatic field in the production method of the present invention. 実施例1で得られた繊維構造体の走査型電子顕微鏡写真Scanning electron micrograph of the fiber structure obtained in Example 1. 実施例2で得られた繊維構造体の走査型電子顕微鏡写真Scanning electron micrograph of the fiber structure obtained in Example 2. 実施例3で得られた繊維構造体の走査型電子顕微鏡写真Scanning electron micrograph of the fiber structure obtained in Example 3. 実施例4で得られた繊維構造体の走査型電子顕微鏡写真Scanning electron micrograph of the fiber structure obtained in Example 4. 実施例5で得られた繊維構造体の走査型電子顕微鏡写真Scanning electron micrograph of the fiber structure obtained in Example 5. 比較例1で得られた繊維構造体の走査型電子顕微鏡写真Scanning electron micrograph of the fiber structure obtained in Comparative Example 1. 実施例6と比較例2のAlamarblueの測定の結果である。It is a result of measurement of Alamarblue of Example 6 and Comparative Example 2.

符号の説明Explanation of symbols

1. ノズル
2. 紡糸液
3. 紡糸液保持槽
4. 電極
5. 繊維状物質捕集電極
6. 高電圧発生器
7. ノズル
8. 紡糸液
9. 紡糸液保持槽
10. 電極
11. 繊維状物質捕集電極
12. 高電圧発生器
発明の好ましい実施形態
以下、本発明について詳述する。なお、これらの実施例等および説明は本発明を例示するものであり、本発明の範囲を制限するものではない。本発明の趣旨に合致する限り他の実施形態も本発明の範疇に属し得ることは言うまでもない。
本発明は、脂肪族ポリエステル100重量部に対して、リン脂質を0.01〜100重量部含有した繊維構造体である。脂肪族ポリエステル100重量部に対してリン脂質の含有量は、好ましくは0.1〜20重量部、さらに好ましくは0.1〜10重量部である。リン脂質の含有量が100重量部以上であると、繊維の安定性に欠ける場合がある。
本発明に用いる繊維構造体の平均繊維径は0.05〜50μmであることが好ましい。平均繊維径が0.05μmより小さいと、細胞培養時や細胞培養後生体内に移植した際の分解が速すぎるため好ましくない。また、平均繊維径が50μmより大きいと、細胞培養に十分な表面積を得ることができず、好ましくない。平均繊維径は0.1〜20μmがより好ましい。
本発明に用いる繊維構造体の平均多孔化率は3〜90%が好ましく、より好ましくは11〜90%であり、さらに好ましくは30〜90%である。
ここでいう平均多孔化率とは、繊維表面全体の面積に対する細孔面積の割合を意味し、繊維構造体の2万倍の走査型電子顕微鏡写真を画像処理ソフト(next New Qube)を用いて2値化処理を行い、求めたものをいう。
平均多孔化率が3〜11%の場合は、十分な細胞接着効果が得られない場合があるので、さらに表面に凹凸を持たせることで、好ましく十分な細胞接着効果を提供できる。平均多孔化率が11%以上の場合も、さらに表面に凹凸を有するとさらに優れた細胞接着効果が得られ好ましい。
平均多孔化率が30%より大きいと、より優れた細胞接着効果が得られる。
また平均多孔化率が90%より大きいと、繊維としての強度を保つことができないことがある。
繊維構造体表面の凹み部の平均孔径(直径)は0.001〜10μmであることが好ましい。より好ましくは、0.005〜5μm、より好ましくは0.01〜1μmである。凹み部の平均孔径は走査型電子顕微鏡写真を撮影し、その写真からn=20にて、凹み部の直径を測定した平均値を算出することにより求めることができる。
本発明に用いる脂肪族ポリエステルとしては、ポリ乳酸、ポリグリコール酸、ポリカプロラクトン、ポリブチレンサクシネート、ポリエチレンサクシネート、およびこれらの共重合体などが挙げられる。これらのうち、脂肪族ポリステルとしては、ポリ乳酸、ポリグリコール酸、乳酸−グリコール酸共重合体、ポリカプロラクトン、乳酸−カプロラクトン共重合体が好ましく、特にポリ乳酸、ポリカプロラクトンが好ましい。
脂肪族ポリエステルの重量平均分子量は2万〜100万であることが好ましい。より好ましくは重量平均分子量は5万〜50万である。
本発明に用いるリン脂質は、動物組織から抽出したものでも、また人工的に合成して製造したものでもその起源を問うことなく使用できる。リン脂質としてはホスファチジルエタノールアミン、ホスファチジルコリン、ホスファチジルセリン、ホスファチジルグリセロールおよびそれらの誘導体からなる群から選択されてなるものを利用することが望ましい。好ましくはホスファチジルエタノールアミンまたはホスファチジルコリンである。さらに好ましくはL−α−ホスファチジルエタノールアミンジオレオイル、またはL−α−ホスファチジルコリンジオレオイルである。
本発明に用いる繊維構造体とは、1種または複数種の繊維が積層され、織り、編まれ若しくはその他の手法により形成された3次元の構造体を指すが、短繊維であるフィラメントおよびフィラメントを複数集めたヤーンも包含するものとする。具体的な繊維構造体の形態としては、例えば不織布、織布、編布、チューブ、メッシュ、などが好ましく挙げられる。より好ましい形態は、不織布である。
リン脂質を含有する繊維と、リン脂質を含有しない繊維の複合体も含む。
繊維構造体の平均見掛け密度は10〜350kg/mであることが好ましい。ここで平均見掛け密度とは、繊維構造体の面積、平均厚、質量から割り出した密度を意味する。
平均見掛け密度が350kg/mより大きいと、細胞培養時に栄養分などを含む溶液が繊維構造体の内部まで十分に浸透しないため繊維構造体表面にしか細胞が培養されない場合がある。また、平均見掛け密度が10kg/mより小さいと、細胞培養時に必要な力学強度を保つことが出来ない場合がある。好ましい平均見掛け密度は10〜250kg/mである。
本発明の繊維構造体を製造する方法としては、静電紡糸法、スパンボンド法、メルトブロー法、フラッシュ紡糸法等が挙げられる。その中でも、静電紡糸法が操作性や簡便性から好ましい。以下静電紡糸法により製造する方法について詳細に説明する。
本発明で用いる静電紡糸法では脂肪族ポリエステルを、揮発性溶媒に溶解した溶液を電極間に形成された静電場中に吐出し、溶液を電極に向けて曳糸し、形成される繊維状物質を捕集基板に累積することによって繊維構造体を得ることができる。繊維状物質とは既に溶液の溶媒が完全に留去されて繊維構造体となっている状態のみならず、いまだ溶液の溶媒を含んでいる状態も示している。
まず静電紡糸法で用いる装置について説明する。本発明で用いられる電極は、金属、無機物、または有機物のいかなるものでも導電性を示しさえすれば良い。また、絶縁物上に導電性を示す金属、無機物、または有機物の薄膜を持つものであっても良い。本発明における静電場は一対又は複数の電極間で形成されており、いずれの電極に高電圧を印加しても良い。これは例えば電圧値が異なる高電圧の電極が2つ(例えば15kVと10kV)と、アースにつながった電極の合計3つの電極を用いる場合も含み、または3本を越える数の電極を使う場合も含むものとする。
次に静電紡糸法による本発明の繊維構造体の好ましい製造手法について詳細に説明する。まず脂肪族ポリエステル、リン脂質、および揮発性溶媒からなる溶液を製造する段階がある。本発明の製造方法における溶液中の脂肪族ポリエステルの濃度は1〜30重量%であることが好ましい。脂肪族ポリエステルの濃度が1重量%より小さいと、濃度が低すぎるため繊維構造体を形成することが困難となり好ましくない。また、30重量%より大きいと溶液の粘度が増大するために、電極間により高電圧をかける必要が生じるため好ましくない。より好ましい脂肪族ポリエステルの濃度は2〜25重量%である。
本発明の揮発性溶媒としては、脂肪族ポリエステルを溶解することができれば特に限定されない。揮発性溶媒としては、例えば非水溶性である塩化メチレン、クロロホルム、四塩化炭素などのハロゲン元素含有炭化水素や、任意の割合で水を溶解することができるアセトン、メタノール、エタノール、プロパノール、イソプロパノール、トルエン、テトラヒドロフラン、1,1,1,3,3,3−ヘキサフルオロイソプロパノール、水、1,4−ジオキサン、シクロヘキサン、シクロヘキサノン、N,N−ジメチルホルムアミド、アセトニトリルなどが挙げられる。これらのうち、繊維表面の多孔化を促進させるには、特に揮発性の高い塩化メチレン、クロロホルム、アセトン、テトラヒドロフランが特に好ましい。
これらの溶媒は単独で用いても良く、複数の溶媒を組み合わせても良い。また本発明の目的を損なわない範囲で、他の溶媒を併用しても良い。
次に前記溶液を静電紡糸法にて紡糸する段階について説明する。該溶液を静電場中に吐出するには、任意の方法を用いることが出来る。例えば、一例として図1を用いて以下説明する。溶液2をノズルに供給することによって、溶液を静電場中の適切な位置に置き、そのノズルから溶液を電界によって曳糸して繊維化させる。このためには適宜な装置を用いることができ、例えば注射器の筒状の溶液保持槽3の先端部に適宜の手段、例えば高電圧発生器6にて電圧をかけた注射針状の溶液噴出ノズル1を設置して、溶液をその先端まで導く。接地した繊維状物質捕集電極5から適切な距離に該噴出ノズル1の先端を配置し、溶液2が該噴出ノズル1の先端を出るときにこの先端と繊維状物質捕集電極5の間にて繊維状物質を形成させる。
また当業者には自明の方法で該溶液の微細滴を静電場中に導入することもできる。一例として図2を用いて以下に説明する。その際の唯一の要件は液滴を静電場中に置いて、繊維化が起こりうるような距離に繊維状物質捕集電極11から離して保持することである。例えば、ノズル7を有する溶液保持槽9中の溶液8に直接、直接繊維状物質捕集電極11に対抗する電極10を挿入しても良い。
該溶液をノズルから静電場中に供給する場合、数個のノズルを用いて繊維状物質の生産速度を上げることもできる。電極間の距離は、帯電量、ノズル寸法、紡糸液流量、紡糸液濃度等に依存するが、10kV程度のときには5〜20cmの距離が適当であった。また、印加される静電気電位は、一般に3〜100kV、好ましくは5〜50kV、一層好ましくは5〜30kVである。所望の電位は任意の適切な方法で作れば良い。
上記説明は、電極が捕集基板を兼ねる場合であるが、電極間に捕集基板となりうる物を設置することで、電極と別に捕集基板を設け、そこに繊維構造体を捕集することが出来る。この場合、例えばベルト状物質を電極間に設置して、これを捕集基板とすることで、連続的な生産も可能となる。
本発明において、ノズルと捕集基板の間の相対湿度を20%以上に維持すると、上記表面構造を有する繊維を簡便に得ることができ、好ましい。より好ましい相対湿度は25〜95%である。
最後に捕集基板に累積される繊維積層体を得る段階について説明する。本発明においては、該溶液を捕集基板に向けて曳糸する間に、条件に応じて溶媒が蒸発して繊維状物質が形成される。通常の室温であれば捕集基板上に捕集されるまでの間に溶媒は完全に蒸発するが、もし溶媒蒸発が不十分な場合は減圧条件下で曳糸しても良い。また、曳糸する温度は溶媒の蒸発挙動や紡糸液の粘度に依存するが、通常は、0〜50℃である。
本発明の繊維構造体は、上記繊維構造体単独で構成されていても良いが、他の部材と組み合わされていても良い。また、本発明の細胞培養基材は、その特徴を損なわない範囲であれば、細胞成長因子や細胞増殖因子などの蛋白質や、コラーゲン等の細胞外マトリクス等を組み合わせても良い。
1. Nozzle 2. Spinning solution 3. Spinning liquid holding tank 4. Electrode 5. Fibrous substance collecting electrode 6. High voltage generator 7. Nozzle 8. Spinning solution 9. Spinning liquid holding tank 10. Electrode 11. Fibrous substance collecting electrode 12. Preferred Embodiments of High Voltage Generator Invention Hereinafter, the present invention will be described in detail. It should be noted that these examples and the like and the explanations only exemplify the present invention and do not limit the scope of the present invention. It goes without saying that other embodiments can be included in the scope of the present invention as long as they match the spirit of the present invention.
The present invention is a fiber structure containing 0.01 to 100 parts by weight of a phospholipid with respect to 100 parts by weight of an aliphatic polyester. The content of the phospholipid is preferably 0.1 to 20 parts by weight, more preferably 0.1 to 10 parts by weight, based on 100 parts by weight of the aliphatic polyester. If the phospholipid content is 100 parts by weight or more, the stability of the fiber may be insufficient.
The average fiber diameter of the fiber structure used in the present invention is preferably 0.05 to 50 μm. When the average fiber diameter is smaller than 0.05 μm, it is not preferable because the decomposition at the time of cell culture or when transplanted in vivo after cell culture is too fast. Further, if the average fiber diameter is larger than 50 μm, a sufficient surface area for cell culture cannot be obtained, which is not preferable. The average fiber diameter is more preferably 0.1 to 20 μm.
The average porosity of the fiber structure used in the present invention is preferably 3 to 90%, more preferably 11 to 90%, and further preferably 30 to 90%.
The average porosity here means the ratio of the pore area to the area of the entire fiber surface, and a scanning electron micrograph of 20,000 times of the fiber structure is obtained using image processing software (next New Qube) It is the one obtained by performing binarization processing.
When the average porosity is 3 to 11%, a sufficient cell adhesion effect may not be obtained, and therefore by providing the surface with unevenness, a sufficient cell adhesion effect can be preferably provided. Even when the average porosity is 11% or more, it is preferable that the surface has irregularities to obtain a more excellent cell adhesion effect.
When the average porosity is more than 30%, a better cell adhesion effect can be obtained.
If the average porosity is greater than 90%, the strength of the fiber may not be maintained.
The average pore diameter (diameter) of the concave portion on the surface of the fiber structure is preferably 0.001 to 10 μm. The thickness is more preferably 0.005 to 5 μm, and more preferably 0.01 to 1 μm. The average pore diameter of the depressions can be obtained by taking a scanning electron microscope photograph and calculating the average value of the diameters of the depressions measured at n=20 from the photograph.
Examples of the aliphatic polyester used in the present invention include polylactic acid, polyglycolic acid, polycaprolactone, polybutylene succinate, polyethylene succinate, and copolymers thereof. Among these, as the aliphatic polyester, polylactic acid, polyglycolic acid, lactic acid-glycolic acid copolymer, polycaprolactone and lactic acid-caprolactone copolymer are preferable, and polylactic acid and polycaprolactone are particularly preferable.
The weight average molecular weight of the aliphatic polyester is preferably 20,000 to 1,000,000. More preferably, the weight average molecular weight is 50,000 to 500,000.
The phospholipid used in the present invention can be used regardless of its origin, whether it is extracted from animal tissue or artificially synthesized. As the phospholipid, it is desirable to use one selected from the group consisting of phosphatidylethanolamine, phosphatidylcholine, phosphatidylserine, phosphatidylglycerol and derivatives thereof. Preferred is phosphatidyl ethanolamine or phosphatidyl choline. More preferred is L-α-phosphatidylethanolamine dioleoyl, or L-α-phosphatidylcholine dioleoyl.
The fibrous structure used in the present invention refers to a three-dimensional structure formed by laminating one kind or plural kinds of fibers, weaving, knitting or other methods. It also includes the collected yarns. Preferred specific examples of the fiber structure include non-woven fabric, woven fabric, knitted fabric, tube and mesh. A more preferable form is a non-woven fabric.
It also includes a complex of fibers containing phospholipids and fibers not containing phospholipids.
The average apparent density of the fibrous structure is preferably 10 to 350 kg/m 3 . Here, the average apparent density means the density calculated from the area, average thickness, and mass of the fiber structure.
If the average apparent density is more than 350 kg/m 3 , the solution containing nutrients or the like does not sufficiently penetrate into the inside of the fiber structure during cell culture, and thus cells may be cultured only on the surface of the fiber structure. If the average apparent density is less than 10 kg/m 3 , the mechanical strength required during cell culture may not be maintained. A preferable average apparent density is 10 to 250 kg/m 3 .
Examples of the method for producing the fiber structure of the present invention include an electrostatic spinning method, a spun bond method, a melt blow method, a flash spinning method and the like. Among them, the electrostatic spinning method is preferable from the viewpoint of operability and simplicity. The method of manufacturing by the electrostatic spinning method will be described in detail below.
In the electrospinning method used in the present invention, a solution of an aliphatic polyester dissolved in a volatile solvent is discharged into an electrostatic field formed between electrodes, and the solution is spun to form a fibrous fiber. A fibrous structure can be obtained by accumulating substances on the collection substrate. The fibrous substance indicates not only a state in which the solvent of the solution has been completely distilled off to form a fibrous structure, but also a state in which the solvent of the solution is still contained.
First, an apparatus used in the electrostatic spinning method will be described. The electrode used in the present invention may be any metal, inorganic material, or organic material as long as it exhibits conductivity. Further, it may have a thin film of a conductive metal, an inorganic material, or an organic material on the insulator. The electrostatic field in the present invention is formed between a pair of or a plurality of electrodes, and a high voltage may be applied to any of the electrodes. This includes, for example, two high voltage electrodes with different voltage values (for example, 15 kV and 10 kV) and a total of three electrodes connected to the ground, or a case where more than three electrodes are used. Shall be included.
Next, a preferable method for producing the fiber structure of the present invention by the electrostatic spinning method will be described in detail. First there is the step of producing a solution consisting of an aliphatic polyester, a phospholipid and a volatile solvent. The concentration of the aliphatic polyester in the solution in the production method of the present invention is preferably 1 to 30% by weight. If the concentration of the aliphatic polyester is less than 1% by weight, the concentration is too low and it is difficult to form a fiber structure, which is not preferable. On the other hand, if it is more than 30% by weight, the viscosity of the solution increases, so that it is necessary to apply a higher voltage between the electrodes, which is not preferable. The more preferable concentration of the aliphatic polyester is 2 to 25% by weight.
The volatile solvent of the present invention is not particularly limited as long as it can dissolve the aliphatic polyester. As the volatile solvent, for example, water-insoluble methylene chloride, chloroform, a halogen element-containing hydrocarbon such as carbon tetrachloride, and acetone that can dissolve water at an arbitrary ratio, methanol, ethanol, propanol, isopropanol, Toluene, tetrahydrofuran, 1,1,1,3,3,3-hexafluoroisopropanol, water, 1,4-dioxane, cyclohexane, cyclohexanone, N,N-dimethylformamide, acetonitrile and the like can be mentioned. Of these, methylene chloride, chloroform, acetone, and tetrahydrofuran, which have particularly high volatility, are particularly preferable for promoting the porosity of the fiber surface.
These solvents may be used alone or a plurality of solvents may be combined. Further, other solvents may be used in combination as long as the object of the present invention is not impaired.
Next, the step of spinning the solution by electrostatic spinning will be described. Any method can be used to discharge the solution into an electrostatic field. For example, the following description will be given with reference to FIG. 1 as an example. By supplying the solution 2 to the nozzle, the solution is placed at an appropriate position in the electrostatic field, and the solution is spun by the electric field from the nozzle to be fiberized. For this purpose, an appropriate device can be used, for example, an appropriate means at the tip of the cylindrical solution holding tank 3 of the syringe, for example, an injection needle-shaped solution ejection nozzle in which a voltage is applied by the high voltage generator 6. Install 1 and lead the solution to its tip. The tip of the ejection nozzle 1 is arranged at an appropriate distance from the grounded fibrous substance collection electrode 5, and when the solution 2 exits the tip of the ejection nozzle 1, the tip of the ejection nozzle 1 and the fibrous substance collection electrode 5 are separated from each other. To form a fibrous material.
Those skilled in the art will also be able to introduce microdroplets of the solution into the electrostatic field by methods that are obvious. An example will be described below with reference to FIG. The only requirement in that case is to place the droplet in an electrostatic field and keep it away from the fibrous material collecting electrode 11 at a distance where fibrosis can occur. For example, the electrode 10 that directly opposes the fibrous substance collecting electrode 11 may be directly inserted into the solution 8 in the solution holding tank 9 having the nozzle 7.
When the solution is supplied from the nozzle into the electrostatic field, the production rate of the fibrous substance can be increased by using several nozzles. The distance between the electrodes depends on the charge amount, the nozzle size, the spinning solution flow rate, the spinning solution concentration, etc., but a distance of 5 to 20 cm was suitable when it was about 10 kV. The applied electrostatic potential is generally 3 to 100 kV, preferably 5 to 50 kV, and more preferably 5 to 30 kV. The desired potential may be created by any suitable method.
The above description is for the case where the electrode also serves as the collecting substrate, but by providing an object that can serve as the collecting substrate between the electrodes, a collecting substrate is provided separately from the electrodes, and the fiber structure is collected there. Can be done. In this case, for example, a belt-shaped substance is installed between the electrodes and is used as a collection substrate to enable continuous production.
In the present invention, maintaining the relative humidity between the nozzle and the collection substrate at 20% or more is preferable because the fiber having the above-mentioned surface structure can be easily obtained. A more preferable relative humidity is 25 to 95%.
Finally, the step of obtaining a fiber laminate that is accumulated on the collection substrate will be described. In the present invention, the solvent evaporates depending on the conditions to form a fibrous substance while the solution is drawn toward the collection substrate. At normal room temperature, the solvent completely evaporates before being collected on the collecting substrate, but if the solvent evaporation is insufficient, the solvent may be drawn under reduced pressure. The spinning temperature depends on the evaporation behavior of the solvent and the viscosity of the spinning solution, but is usually 0 to 50°C.
The fiber structure of the present invention may be composed of the above fiber structure alone, or may be combined with other members. The cell culture substrate of the present invention may be combined with proteins such as cell growth factors and cell growth factors, extracellular matrix such as collagen, etc., as long as the characteristics thereof are not impaired.

以下、実施例により本発明の実施の形態を説明するが、これらは本発明の発明を制限するものではない。
平均多孔化率は、得られた繊維構造体の2万倍の走査型電子顕微鏡写真を画像処理ソフト(next New Qube)を用いて2値化処理を行い、求めた。繊維表面の孔径は、得られた繊維構造体の2万倍の走査型電子顕微鏡写真からn=20にて、孔の直径を測定した平均値を算出した。
実施例1
ポリ乳酸(島津製作所:商品名「Lacty 9031」、重量平均分子量168,000)100重量部とホスファチジルエタノールアミン ジオレオイル(和光純薬)0.5重量部を塩化メチレン(和光純薬工業、特級)899.5重量部に室温(29℃)にて溶解し、溶液を作成した。図1にしめす装置を用いて、該溶液を繊維状物質捕集電極5に15分間吐出した。噴出ノズル1の内径は0.8mm、電圧は12kV、噴出ノズル1から繊維状物質捕集電極5までの距離は20cm、相対湿度39%であった。得られた繊維構造体を走査型電子顕微鏡(日立製作所S−2400)で測定したところ、平均繊維径は10μm、平均多孔化率は36.7%、平均孔径は0.52μm、見かけ密度は209kg/mであった。図3に走査型電子顕微鏡写真を示す。
実施例2
ポリ乳酸(島津製作所:商品名「Lacty 9031」、重量平均分子量168,000)100重量部とホスファチジルエタノールアミン ジオレオイル(和光純薬)10重量部を塩化メチレン(和光純薬工業、特級)890重量部に室温(26℃)にて溶解し、溶液を作成した。図1にしめす装置を用いて、該溶液を繊維状物質捕集電極5に15分間吐出した。噴出ノズル1の内径は0.8mm、電圧は12kV、噴出ノズル1から繊維状物質捕集電極5までの距離は20cm、相対湿度39%であった。得られた繊維構造体を走査型電子顕微鏡(日立製作所S−2400)で測定したところ、平均繊維径は10μm、平均多孔化率は66.1%、平均孔径は0.98μm、見かけ密度は212kg/mであった。図4に走査型電子顕微鏡写真を示す。
実施例3
ポリ乳酸(島津製作所:商品名「Lacty 9031」、重量平均分子量168,000)100重量部とホスファチジルコリン ジオレオイル(和光純薬)0.5重量部を塩化メチレン(和光純薬工業、特級)899.5重量部に室温(29℃)にて溶解し、溶液を作成した。図1にしめす装置を用いて、該溶液を繊維状物質捕集電極5に15分間吐出した。噴出ノズル1の内径は0.8mm、電圧は12kV、噴出ノズル1から繊維状物質捕集電極5までの距離は20cm、相対湿度39%であった。得られた繊維構造体を走査型電子顕微鏡(日立製作所S−2400)で測定したところ、平均繊維径は8μm、平均多孔化率は25.8%、平均孔径は0.11μm、見かけ密度は208kg/mであった。図5に走査型電子顕微鏡写真を示す。
実施例4
ポリ乳酸(島津製作所:商品名「Lacty 9031」、重量平均分子量168,000)100重量部とホスファチジルエタノールアミン ジオレオイル(和光純薬)0.5重量部を塩化メチレン(和光純薬工業、特級)449.75重量部、N,N−ジメチルホルムアミド449.75重量部に室温(29℃)にて溶解し、溶液を作成した。図1にしめす装置を用いて、該溶液を繊維状物質捕集電極5に15分間吐出した。噴出ノズル1の内径は0.8mm、電圧は12kV、噴出ノズル1から繊維状物質捕集電極5までの距離は10cm、相対湿度39%であった。得られた繊維構造体を走査型電子顕微鏡(日立製作所S−2400)で測定したところ、平均繊維径は0.7μm、平均多孔化率は3%、平均孔径は0.032μm、見かけ密度は210kg/mであった。図6に走査型電子顕微鏡写真を示す。
実施例5
ポリ乳酸(島津製作所:商品名「Lacty 9031」、重量平均分子量168,000)100重量部とホスファチジルエタノールアミン ジオレオイル(和光純薬)0.1重量部を塩化メチレン(和光純薬工業、特級)899.9重量部に室温(29℃)にて溶解し、溶液を作成した。図1にしめす装置を用いて、該溶液を繊維状物質捕集電極5に13分間吐出した。噴出ノズル1の内径は0.8mm、電圧は12kV、噴出ノズル1から繊維状物質捕集電極5までの距離は20cm、相対湿度33%であった。得られた繊維構造体を走査型電子顕微鏡(日立製作所S−2400)で測定したところ、平均繊維径は8μm、平均多孔化率は35.4%、平均孔径は0.63μm、見かけ密度は214kg/mであった。図7に走査型電子顕微鏡写真を示す。
比較例1
ポリ乳酸(島津製作所:商品名「Lacty 9031」、重量平均分子量168,000)10重量部を塩化メチレン(和光純薬工業、特級)90重量部に室温(22℃)にて溶解し、溶液を作成した。図1にしめす装置を用いて、該溶液を繊維状物質捕集電極5に13分間吐出した。噴出ノズル1の内径は0.8mm、電圧は12kV、噴出ノズル1から繊維状物質捕集電極5までの距離は20cm、相対湿度36%であった。得られた繊維構造体を走査型電子顕微鏡(日立製作所S−2400)で測定したところ、平均繊維径は3μm、平均多孔化率は10.5%、見かけ密度は215kg/mであった。図8に走査型電子顕微鏡写真を示す。
実施例6:細胞培養評価
実施例1で得られた繊維構造体を直径12mmの円形に切り出し、滅菌のために70%エタノール水溶液(和光純薬工業)に浸漬し風乾させた後、細胞培養器内で0.25×105Cells/ml/wellでPAE(豚大動脈由来血管内皮細胞)を播種し、6ウェルプレート内に収め、5%CO2、37℃の条件でインキュベーター内で培養を行った。細胞増殖能をAlamarblueにて1日目および4日目に測定した。測定は、波長530nmの励起光を用いて出現した蛍光590nmを検出した。
結果を図9に示す。
比較例2
比較例1の繊維構造体を使用した以外、実施例6と同様の操作を行った。結果を図9に共に示す。
2標本による有意差検定を行った結果、培養後1日間経過では、実施例6は比較例2との2標本間において、0.001%の危険率で統計的有意差をもって接着性及び増殖性がよいとの結果が得られた。培養後4日間経過では実施例6は比較例2との2標本間において0.001%の危険率で統計的有意差をもって接着性及び増殖性がよいとの結果が得られた。
Hereinafter, embodiments of the present invention will be described with reference to examples, but these do not limit the invention of the present invention.
The average porosity was obtained by performing a binarization process on a scanning electron micrograph of the obtained fiber structure at a magnification of 20,000 using image processing software (next New Qube). The pore diameter of the fiber surface was calculated by averaging the diameter of the pores measured at n=20 from a scanning electron micrograph of the obtained fiber structure at a magnification of 20,000.
Example 1
100 parts by weight of polylactic acid (Shimadzu Corporation: trade name "Lacty 9031", weight average molecular weight 168,000) and 0.5 parts by weight of phosphatidylethanolamine dioleoyl (Wako Pure Chemical Industries) are added to methylene chloride (Wako Pure Chemical Industries, special grade) 899. It was dissolved in 0.5 parts by weight at room temperature (29° C.) to prepare a solution. The solution was discharged to the fibrous substance collecting electrode 5 for 15 minutes using the device shown in FIG. The inner diameter of the ejection nozzle 1 was 0.8 mm, the voltage was 12 kV, the distance from the ejection nozzle 1 to the fibrous material collecting electrode 5 was 20 cm, and the relative humidity was 39%. When the obtained fiber structure was measured by a scanning electron microscope (Hitachi S-2400), the average fiber diameter was 10 μm, the average porosity was 36.7%, the average pore size was 0.52 μm, and the apparent density was 209 kg. /M 3 . FIG. 3 shows a scanning electron micrograph.
Example 2
Polylactic acid (Shimadzu: trade name "Lacty 9031", weight average molecular weight 168,000) 100 parts by weight and phosphatidylethanolamine dioleoyl (Wako Pure Chemical Industries) 10 parts by weight methylene chloride (Wako Pure Chemical Industries, special grade) 890 parts by weight Was dissolved at room temperature (26° C.) to prepare a solution. The solution was discharged to the fibrous substance collecting electrode 5 for 15 minutes using the device shown in FIG. The inner diameter of the ejection nozzle 1 was 0.8 mm, the voltage was 12 kV, the distance from the ejection nozzle 1 to the fibrous material collecting electrode 5 was 20 cm, and the relative humidity was 39%. When the obtained fiber structure was measured by a scanning electron microscope (Hitachi S-2400), the average fiber diameter was 10 μm, the average porosity was 66.1%, the average pore size was 0.98 μm, and the apparent density was 212 kg. /M 3 . FIG. 4 shows a scanning electron micrograph.
Example 3
Polylactic acid (Shimadzu: trade name "Lacty 9031", weight average molecular weight 168,000) 100 parts by weight and phosphatidylcholine dioleoyl (Wako Pure Chemical Industries) 0.5 parts by weight are methylene chloride (Wako Pure Chemical Industries, special grade) 899.5. A solution was prepared by dissolving in parts by weight at room temperature (29° C.). The solution was discharged to the fibrous substance collecting electrode 5 for 15 minutes using the device shown in FIG. The inner diameter of the ejection nozzle 1 was 0.8 mm, the voltage was 12 kV, the distance from the ejection nozzle 1 to the fibrous material collecting electrode 5 was 20 cm, and the relative humidity was 39%. When the obtained fiber structure was measured with a scanning electron microscope (Hitachi S-2400), the average fiber diameter was 8 μm, the average porosity was 25.8%, the average pore size was 0.11 μm, and the apparent density was 208 kg. /M 3 . FIG. 5 shows a scanning electron micrograph.
Example 4
100 parts by weight of polylactic acid (Shimadzu: trade name "Lacty 9031", weight average molecular weight 168,000) and 0.5 parts by weight of phosphatidylethanolamine dioleoyl (Wako Pure Chemical Industries) were added to methylene chloride (Wako Pure Chemical Industries, special grade) 449. 0.75 parts by weight and N,N-dimethylformamide 449.75 parts by weight were dissolved at room temperature (29° C.) to prepare a solution. The solution was discharged to the fibrous substance collecting electrode 5 for 15 minutes using the device shown in FIG. The inner diameter of the ejection nozzle 1 was 0.8 mm, the voltage was 12 kV, the distance from the ejection nozzle 1 to the fibrous substance collecting electrode 5 was 10 cm, and the relative humidity was 39%. When the obtained fiber structure was measured with a scanning electron microscope (Hitachi S-2400), the average fiber diameter was 0.7 μm, the average porosity was 3%, the average pore diameter was 0.032 μm, and the apparent density was 210 kg. /M 3 . FIG. 6 shows a scanning electron micrograph.
Example 5
100 parts by weight of polylactic acid (Shimadzu Corporation: trade name "Lacty 9031", weight average molecular weight 168,000) and 0.1 part by weight of phosphatidylethanolamine dioleoyl (Wako Pure Chemical Industries) are added to methylene chloride (Wako Pure Chemical Industries, special grade) 899. It was dissolved in room temperature (29° C.) in 0.9 parts by weight to prepare a solution. The solution was discharged onto the fibrous substance collecting electrode 5 for 13 minutes by using the device shown in FIG. The inner diameter of the ejection nozzle 1 was 0.8 mm, the voltage was 12 kV, the distance from the ejection nozzle 1 to the fibrous substance collection electrode 5 was 20 cm, and the relative humidity was 33%. When the obtained fiber structure was measured with a scanning electron microscope (Hitachi S-2400), the average fiber diameter was 8 μm, the average porosity was 35.4%, the average pore size was 0.63 μm, and the apparent density was 214 kg. /M 3 . FIG. 7 shows a scanning electron micrograph.
Comparative Example 1
10 parts by weight of polylactic acid (Shimadzu Corporation: trade name "Lacty 9031", weight average molecular weight 168,000) was dissolved in 90 parts by weight of methylene chloride (Wako Pure Chemical Industries, special grade) at room temperature (22°C) to prepare a solution. Created. The solution was discharged onto the fibrous substance collecting electrode 5 for 13 minutes by using the device shown in FIG. The inner diameter of the ejection nozzle 1 was 0.8 mm, the voltage was 12 kV, the distance from the ejection nozzle 1 to the fibrous substance collection electrode 5 was 20 cm, and the relative humidity was 36%. When the obtained fiber structure was measured with a scanning electron microscope (Hitachi S-2400), the average fiber diameter was 3 μm, the average porosity was 10.5%, and the apparent density was 215 kg/m 3 . FIG. 8 shows a scanning electron micrograph.
Example 6: Evaluation of cell culture The fibrous structure obtained in Example 1 was cut into a circle having a diameter of 12 mm, immersed in a 70% aqueous ethanol solution (Wako Pure Chemical Industries) for sterilization, air-dried, and then a cell incubator. PAE (porcine aorta-derived vascular endothelial cells) was seeded at 0.25×10 5 cells/ml/well, placed in a 6-well plate, and cultured in an incubator under the conditions of 5% CO 2 and 37° C. Cell proliferation capacity was measured on Alamarblue on days 1 and 4. In the measurement, the fluorescence of 590 nm that appeared using the excitation light of wavelength 530 nm was detected.
The results are shown in Fig. 9.
Comparative example 2
The same operation as in Example 6 was performed except that the fiber structure of Comparative Example 1 was used. The results are shown together in FIG.
As a result of performing a significant difference test using two specimens, in one day after culturing, Example 6 showed a statistically significant difference in adhesiveness and proliferation between the two specimens of Comparative Example 2 and Comparative Example 2 at a risk rate of 0.001%. The result was good. After 4 days of culturing, the results of Example 6 showed that the two specimens of Comparative Example 2 and Adhesiveness and Proliferativeness were good with a statistically significant difference at a risk rate of 0.001%.

Claims (8)

脂肪族ポリエステル100重量部に対して、リン脂質を0.01〜100重量部含有し、平均繊維径が0.05〜50μmであることを特徴とした繊維構造体。  A fiber structure containing 0.01 to 100 parts by weight of a phospholipid with respect to 100 parts by weight of an aliphatic polyester and having an average fiber diameter of 0.05 to 50 μm. 脂肪族ポリエステル100重量部に対して、リン脂質を0.01〜20重量部含有した請求項1に記載の繊維構造体。  The fibrous structure according to claim 1, which contains 0.01 to 20 parts by weight of a phospholipid with respect to 100 parts by weight of an aliphatic polyester. 前記繊維構造体の繊維表面の平均多孔化率が3%〜90%であることを特徴とする請求項1に記載の繊維構造体。  The fiber structure according to claim 1, wherein the average porosity of the fiber surface of the fiber structure is 3% to 90%. 該脂肪族ポリエステルがポリ乳酸、ポリグリコール酸、ポリカプロラクトン、ポリブチレンサクシネート、ポリエチレンサクシネート、およびこれらの共重合体からなる群から選択される少なくとも一つの高分子である請求項1に記載の繊維構造体。  The aliphatic polyester is at least one polymer selected from the group consisting of polylactic acid, polyglycolic acid, polycaprolactone, polybutylene succinate, polyethylene succinate, and copolymers thereof. Fiber structure. 該リン脂質がホスファチジルエタノールアミン、ホスファチジルコリン、ホスファチジルセリン、ホスファチジルグリセロール、カルジオリピン、ホスファチジルイノシトール、スフィンゴミエリン、ホスファチジン酸、プラズマローゲンおよびそれらの誘導体からなる群から選択されてなる請求項1に記載の繊維構造体。  The fibrous structure according to claim 1, wherein the phospholipid is selected from the group consisting of phosphatidylethanolamine, phosphatidylcholine, phosphatidylserine, phosphatidylglycerol, cardiolipin, phosphatidylinositol, sphingomyelin, phosphatidic acid, plasmalogen and derivatives thereof. . 該リン脂質がホスファチジルエタノールアミンまたはホスファチジルコリンであることを特徴とする請求項1に記載の繊維構造体。  The fibrous structure according to claim 1, wherein the phospholipid is phosphatidylethanolamine or phosphatidylcholine. 該リン脂質がL−α−ホスファチジルエタノールアミンジオレオイルまたはL−α−ホスファチジルコリンジオレオイルであることを特徴とする請求項6に記載の繊維構造体。  The fibrous structure according to claim 6, wherein the phospholipid is L-α-phosphatidylethanolamine dioleoyl or L-α-phosphatidylcholine dioleoyl. 脂肪族ポリエステルおよびリン脂質を揮発性溶媒に溶解した溶液を製造し、該溶液を静電紡糸法にて紡糸し、捕集基板上に累積される繊維構造体を得る段階を含む、請求項1に記載の繊維構造体の製造方法。  A method comprising: producing a solution of an aliphatic polyester and a phospholipid dissolved in a volatile solvent and spinning the solution by an electrostatic spinning method to obtain a fibrous structure accumulated on a collection substrate. The method for producing a fiber structure according to.
JP2006532769A 2004-08-26 2005-08-25 Fiber structure containing phospholipids Active JP4354996B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004246432 2004-08-26
JP2004246432 2004-08-26
PCT/JP2005/015958 WO2006022430A1 (en) 2004-08-26 2005-08-25 Fiber structure containing phospholipid

Publications (2)

Publication Number Publication Date
JPWO2006022430A1 true JPWO2006022430A1 (en) 2008-05-08
JP4354996B2 JP4354996B2 (en) 2009-10-28

Family

ID=35967624

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006532769A Active JP4354996B2 (en) 2004-08-26 2005-08-25 Fiber structure containing phospholipids

Country Status (3)

Country Link
JP (1) JP4354996B2 (en)
TW (1) TW200613016A (en)
WO (1) WO2006022430A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012207350A (en) * 2011-03-30 2012-10-25 Teijin Ltd Nonwoven fabric excellent in flexibility and water retentivity, and method for producing the same

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102597350A (en) * 2009-11-11 2012-07-18 帝人株式会社 Molded fiber article
JPWO2011115281A1 (en) * 2010-03-16 2013-07-04 帝人株式会社 Fiber molded body
JP5400706B2 (en) * 2010-05-24 2014-01-29 帝人株式会社 Fiber molded body
WO2012023594A1 (en) 2010-08-16 2012-02-23 帝人株式会社 Low-chargeable fibers and process for production thereof
JP5589080B2 (en) * 2010-08-31 2014-09-10 帝人株式会社 Composite of fibrin glue and fiber molded body
CN101949071B (en) * 2010-09-16 2012-04-18 扬州大学 Production method of biodegradable composite fiber
WO2012118236A1 (en) * 2011-03-03 2012-09-07 帝人株式会社 Fiber molded body
JP5856785B2 (en) * 2011-09-21 2016-02-10 帝人株式会社 Sheet-like hemostatic material with excellent hemostatic effect
JP5945462B2 (en) * 2012-06-22 2016-07-05 帝人株式会社 Nonwoven fabric excellent in flexibility and water retention and method for producing the same
CN106012102A (en) * 2014-11-07 2016-10-12 蔡留凤 Biomedical electrospun film

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411792D0 (en) * 1994-06-13 1994-08-03 Zeneca Ltd Polymer composition
DE10040897B4 (en) * 2000-08-18 2006-04-13 TransMIT Gesellschaft für Technologietransfer mbH Nanoscale porous fibers of polymeric materials
KR20020063020A (en) * 2001-01-26 2002-08-01 한국과학기술연구원 Method for Preparing Thin Fiber -Structured Polymer Webs
JP2002371174A (en) * 2001-06-13 2002-12-26 Mitsui Chemicals Inc Resin composition for containing agrochemical

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012207350A (en) * 2011-03-30 2012-10-25 Teijin Ltd Nonwoven fabric excellent in flexibility and water retentivity, and method for producing the same

Also Published As

Publication number Publication date
WO2006022430A1 (en) 2006-03-02
JP4354996B2 (en) 2009-10-28
TW200613016A (en) 2006-05-01

Similar Documents

Publication Publication Date Title
JP4354996B2 (en) Fiber structure containing phospholipids
JP5119144B2 (en) Scaffolding material
Moroni et al. Fiber diameter and texture of electrospun PEOT/PBT scaffolds influence human mesenchymal stem cell proliferation and morphology, and the release of incorporated compounds
Sun et al. Electrospun anisotropic architectures and porous structures for tissue engineering
KR100875189B1 (en) Fibrous three-dimensional porous support for tissue regeneration using electrospinning and its preparation method
JP4481994B2 (en) Bioabsorbable porous material
Li et al. Electrospun nanofibrous scaffolds: production, characterization, and applications for tissue engineering and drug delivery
Ndreu et al. Electrospun biodegradable nanofibrous mats for tissue engineering
Shalumon et al. Fabrication of three-dimensional nano, micro and micro/nano scaffolds of porous poly (lactic acid) by electrospinning and comparison of cell infiltration by Z-stacking/three-dimensional projection technique
Chung et al. Nanofibrous scaffolds electrospun from elastomeric biodegradable poly (L-lactide-co-ε-caprolactone) copolymer
JP5563590B2 (en) Fiber molded body
JP4383763B2 (en) Cell culture substrate and method for producing the same
US20060204750A1 (en) Porous fiber, porous fiber structure and method for production thereof
KR20120111381A (en) A double-layered tube-type porous scaffold comprising biodegradable polymer and manufacturing method thereof
JP4056361B2 (en) Polyglycolic acid fiber structure and method for producing the same
JP2011219879A (en) Fiber composite
Unser et al. Electrospinning of nanofibers
Golin Humidity effect on the structure of electrospun core-shell PCL-PEG fibers for tissue regeneration applications
He et al. Electrospraying and electrospinning for nanobiomaterial fabrication
Pupkevičiūtė et al. Analysis of structure of electrospun nonwoven mats from pure PCL nano/micro fibres
Ndreu Electrospun nanofibrous scaffolds for tissue engineering
Lim Development of electrospinning machine for the production of homogeneous and functionally graded multilayer polymeric nanofibers
TW200423976A (en) Anti-adhesive membrane and method for production thereof
JP2023009090A (en) Method for manufacturing porous anti-adhesive film
Gupta et al. Biotextiles as medical implants: 2. Nanofiber structures for medical biotextiles

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090407

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090707

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090730

R150 Certificate of patent or registration of utility model

Ref document number: 4354996

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120807

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120807

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130807

Year of fee payment: 4